PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses - Top-Institutions - MDSpire

PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses

  • By

  • Zongliang Xu

  • Shiyuan Liu

  • Yizhuo Fu

  • Yuqin Zhang

  • Wenzhi Shen

  • Huan Liu

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Immunology
    • Oncology

  • #2

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital
    Dana-Farber Cancer Institute/Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Oncology

Original Source(s)

PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses

  • by Zongliang Xu, Shiyuan Liu, Yizhuo Fu, Yuqin Zhang, Wenzhi Shen, Huan Liu

  • June 18, 2026

Related Content

Association between metabolic syndrome components and the risk of malignant neoplasms of the brain: a nationwide cohort study

Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia

Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment